Skip to content

Early antiretroviral treatment reduces, but does not eliminate HIV reservoir

Jonathan Li presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Experimental agents reverse HIV latency and help immune system fight HIV-infected cells

James Whitney presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Screening for cryptococcal meningitis and adherence support reduce mortality among people starting ART in Africa

Good mental health associated with excellent adherence among people taking ART for prevention

Canada: PrEP use now could save considerable sums in the future

Cabotegravir and rilpivirine effective for HIV maintenance therapy at 96 weeks

FRAX fracture prediction tool underestimates fracture risk in people with HIV

Sustained virological response represents a long-term cure for people with hepatitis C treated with sofosbuvir

Inflammation and gut leakage remains elevated in people with HIV despite early antiretroviral treatment